We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNW
626
DELISTED
Light & Wonder
LNW
| $7.65M | 0.01% |
79,473
+43,249
| +119% | +$3.7M |
|
627
Tetra Tech
TTEK
$9.38B
| $7.64M | 0.01% |
212,559
-258,267
| -55% | -$8.6M |
|
628
Mondelez International
MDLZ
$79.7B
| $7.63M | 0.01% |
113,143
+34,178
| +43% | +$2.28M |
|
629
Cushman & Wakefield Ltd
CWK
$3.32B
| $7.63M | 0.01% |
689,164
+295,615
| +75% | +$2.9M |
|
630
Amalgamated Financial
AMAL
$1.45B
| $7.62M | 0.01% |
244,222
+1,639
| +0.7% | +$48K |
|
631
OFG Bancorp
OFG
$2.2B
| $7.61M | 0.01% |
177,873
+32,113
| +22% | +$1.29M |
|
632
Sterling Infrastructure
STRL
$15.5B
| $7.49M | 0.01% |
32,461
+5,406
| +20% | +$944K |
|
633
Stoneridge
SRI
$203M
| $7.48M | 0.01% |
1,062,490
+356,143
| +50% | +$1.74M |
|
634
Newmark Group
NMRK
$2.82B
| $7.48M | 0.01% |
615,463
+16,304
| +3% | +$182K |
|
635
iRhythm Holdings
IRTC
$3.83B
| $7.46M | 0.01% |
+48,424
| New | +$6.26M |
|
636
Acuity Brands
AYI
$10.2B
| $7.34M | 0.01% |
24,601
+4,040
| +20% | +$1.05M |
|
637
Twilio
TWLO
$37.1B
| $7.3M | 0.01% |
58,717
-2,744
| -4% | -$292K |
|
638
Cameco
CCJ
$46.3B
| $7.3M | 0.01% |
98,284
-38,056
| -28% | -$2.03M |
|
639
Xenon Pharmaceuticals
XENE
$6B
| $7.28M | 0.01% |
232,500
| – | – |
|
|
AII
640
American Integrity Insurance
AII
$515M
| $7.23M | 0.01% |
+393,334
| New | +$6.64M |
|
641
Prothena Corp
PRTA
$467M
| $7.17M | 0.01% |
1,181,087
+634,832
| +116% | +$4.76M |
|
642
Lowe's Companies
LOW
$116B
| $7.09M | 0.01% |
31,936
-20,857
| -40% | -$4.65M |
|
643
Analog Devices
ADI
$181B
| $7.02M | 0.01% |
29,511
-2,157
| -7% | -$449K |
|
644
Revolve Group
RVLV
$1.63B
| $6.97M | 0.01% |
347,664
+102,573
| +42% | +$2.08M |
|
|
BRSP
645
BrightSpire Capital
BRSP
$605M
| $6.97M | 0.01% |
1,380,325
+8,798
| +0.6% | +$44.4K |
|
646
Fastenal
FAST
$58.7B
| $6.96M | 0.01% |
165,750
+163,502
| +7,273% | +$6.63M |
|
|
TBRG
647
DELISTED
TruBridge
TBRG
| $6.92M | 0.01% |
295,386
-165,406
| -36% | -$4.06M |
|
648
Adtran
ADTN
$635M
| $6.89M | 0.01% |
767,743
+5,224
| +0.7% | +$41.7K |
|
649
Viasat
VSAT
$10B
| $6.88M | 0.01% |
470,906
+468,782
| +22,071% | +$4.74M |
|
650
Wendy's
WEN
$1.49B
| $6.86M | 0.01% |
600,686
-24,003
| -4% | -$293K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.